BNTCBenitec Biopharma Inc.
$8.62-46% 1Y
$8.62
$8.0952 weeks$16.52
The financials
Benitec Biopharma Inc. by the numbers
The next results filing is expected around Dec 14, 2026, a quarter after the last one.
| Income statement | Q4 2026 | Q4 2025 | Change |
|---|---|---|---|
| Operating income | −$14M | −$9.8M | n/a |
| Net income | −$13M | −$8.8M | n/a |
| Diluted EPS | −$0.26 | −$0.21 | n/a |